Suppr超能文献

将哈珀-考斯顿因子鉴定为胸苷磷酸化酶,并从培养基中去除干扰磺胺类药物和二氨基嘧啶药敏试验的物质。

Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines.

作者信息

Ferone R, Bushby S R, Burchall J J, Moore W D, Smith D

出版信息

Antimicrob Agents Chemother. 1975 Jan;7(1):91-8. doi: 10.1128/AAC.7.1.91.

Abstract

Rich media support the growth of bacteria in the presence of concentrations of sulfonamides and diaminopyrimidines that are highly inhibitory when the organisms are grown on minimal media. Many such rich media can be made more suitable for susceptibility testing by the incorporation of lysed horse blood. Harper and Cawston characterized the active substance, Harper-Cawston factor (HCF), and later studies indicated it to be a protein. It has now been identified as thymidine phosphorylase. The identification follows from the identical purification pattern of HCF and thymidine phosphorylase activities from horse blood to a high degree of purity. Blood of goats, sheep, oxen, geese, chickens, cows, dogs, rats, and humans had neither biological activity. The identification of HCF as thymidine phosphorylase is consistent with the earlier findings of Koch and Burchall (1971) that most of the interfering effects of rich media could be accounted for by their thymidine contents, and that thymidine is much more active in this respect than is thymine.

摘要

丰富培养基能在存在一定浓度的磺胺类药物和二氨基嘧啶的情况下支持细菌生长,而当这些微生物在基本培养基上生长时,这些药物具有高度抑制作用。通过加入裂解的马血,许多这样的丰富培养基可以变得更适合药敏试验。哈珀和考斯顿对活性物质哈珀 - 考斯顿因子(HCF)进行了表征,后来的研究表明它是一种蛋白质。现在已确定它为胸苷磷酸化酶。这一鉴定是基于从马血中纯化HCF和胸苷磷酸化酶活性的相同模式,直至达到高度纯度。山羊、绵羊、牛、鹅、鸡、奶牛、狗、大鼠和人类的血液均无生物活性。将HCF鉴定为胸苷磷酸化酶与科赫和伯查尔(1971年)早期的研究结果一致,即丰富培养基的大多数干扰作用可归因于其胸苷含量,并且在这方面胸苷比胸腺嘧啶活性更强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21dc/429079/2ec723ba2fdf/aac00319-0099-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验